Clinical trials generate some of the most sensitive data in medicine. Managing this data accurately and in full compliance with regulatory requirements is the core foundation of drug approvals and patient safety. Clinical Data Management Software, known as CDMS, is the electronic infrastructure that ensures accuracy, traceability and complete compliance throughout the clinical trial process.
This guide explains what CDMS is, how it functions, what to look for when selecting one, and how purpose-built platforms like Ledidi Trials are changing the cost and complexity equation for research teams in 2026.
In short
- What is a CDMS? A Clinical Data Management System (CDMS) is validated software used to collect, validate, clean, store, and manage clinical trial data throughout a study's lifecycle.
- Core functions in 2026: Data collection via an eCRF, data validation and query management, local lab management, medical coding, audit trails, and database lock and export.
- How it is executed: Through a validated, cloud-based electronic platform that supports GCP-compliant workflows, role-based access, electronic signatures, and regulatory-ready data exports.
- Importance of software solution: Without a CDMS, clinical trials face data integrity failures, audit risks, and regulatory non-compliance. A purpose-built CDMS reduces errors, accelerates database lock, and prepares data for submission to regulatory bodies including the FDA and EMA.
- Who is Ledidi? Ledidi is a Norwegian software company founded by academic surgeons and software engineers. We provide a unified, secure cloud platform, comprised of Ledidi Core, Ledidi Trials, and Ledidi Registries, that integrates data capture, real-time analytics, and global collaboration.
What is CDMS?
CDMS stands for Clinical Data Management System (CDMS), sometimes referred to interchangeably with clinical data management software, and is a specialised software for collecting, validating, storing, and managing data during a clinical trial.
Additionally, a CDMS is considered a validated electronic platform, meaning that it has been formally tested to meet regulatory requirements for data integration and security, as required by authorities such as the FDA and EMA.
A system for clinical data management is valuable throughout the entire clinical data lifecycle, by governing the data from the first patient data entry to the final database lock and regulatory submission export. Often, it is paired with an Electronic Data Capture (EDC) system.
CDMS vs EDC: What is the difference?
Electronic Data Capture (EDC) is the front-end system that coordinators use to enter data at the point of care. In other words, it operates as the data entry interface and is used for collecting the initial patient data on site. As opposed to EDC systems, CDMS encompasses the entire data cleaning, validation, and regulatory preparation process, making it the broader, back-end system used by data managers and regulatory affairs teams.
| EDC | CDMS | |
|---|---|---|
| Primary role | Front-end data capture | Full data lifecycle management |
| Primary users | Site investigators, coordinators | Data managers, biostatisticians, QA teams |
| Scope | Data entry and basic validation | Edit checks, queries, coding, lock, export |
| Regulatory output | Limited | Submission-ready datasets (SDTM, etc.) |
| Back-end capabilities | Typically limited | Audit trails, lab integration, CDISC export |
| The bottom line | EDC collects clinical trial data | CDMS manages and stores clinical trial data |
The value of a no-code, cloud-based platform
While many modern CDMS platforms include EDC functionality, not many EDC systems have CDMS functionality. Ledidi Trials is a CDMS that includes no-code eCRF (EDC) design, enabling research teams to complete the full clinical research cycle without a separate EDC system.
Functionality in any compliant CDMS software
CDMS software ensures the functionality required for defensible and compliant clinical trials. It supports electronic case report forms (eCRFs), audit trails, query workflows, and database locking. It must ensure data integrity as well as the confidentiality and quality of the information collected throughout the clinical trial.
Data collection
It gathers data from various sources like eCRFs and electronic health records (EHRs). Ledidi Trials' eCRF setup mirrors the actual flow of a clinical trial, guiding users through protocol-driven visit structures and participant follow-up, reducing entry errors at the source.
Data cleaning and validation
It detects anomalies, missing values, or other errors to maintain high data quality. Automated edit checks flag issues, allowing queries to be routed to site staff for resolution and tracked with full traceability.
Local lab management
A compliant CDMS converts lab results from different sites into standardised units and reference ranges, ensuring that data from multiple clinical sites can be compared and analysed accurately. This is particularly relevant for multi-centre trials such as the NHS-based CMR Surgical trial.
Medical coding
It integrates standard medical dictionaries like MedDRA (Medical Dictionary for Regulatory Activities) and the WHO Drug Dictionary to translate clinical terms into standardised codes.
Audit trails
Security is ensured by tracking every single change made to data. Every action is recorded with a timestamp, user ID, and before/after state. This is a requirement under FDA 21 CFR Part 11 and ICH GCP E6(R3).
Reporting and visualisation
By converting the data results into reporting charts or visualised output, it is possible to make even better and more informed decisions based on the data.
Database lock and export
It prepares data for analysis after the data is cleaned. Once all queries are resolved and data is clean, the database is locked to prevent further changes. The CDMS then exports data in regulatory-ready formats.
Who is CDMS relevant for?
- Healthcare providers: Running investigator-initiated trials or post-market studies. Often lack dedicated IT teams, making no-code CDMS solutions particularly relevant.
- Pharmaceutical companies: Managing early-phase to pivotal trials, requiring full regulatory compliance and audit readiness.
- Biotechnology firms: Running observational and early-phase studies, often with lean teams where ease of use and cost-effectiveness are priorities.
- Medical device manufacturers: Generating clinical evidence for MDR, IVDR, and FDA 510(k) or PMA submissions.
- Contract research organisations (CROs): Managing sponsor-led trials across multiple sites and clients, requiring scalable, multi-study platforms.
- Academic research institutions
The clinical data management lifecycle
Clinical data management is the overall process of reviewing, cleaning, and managing data generated during a clinical trial. It follows a defined sequence of steps that to some extent overlap with the functions of the CDMS software. Known as the clinical data management lifecycle, it is comprised of:
- Study setup: Designing the database, CRF building, and defining the data standards.
- Data collection: Gathering all the insights and data to be used in the clinical trial.
- Data cleaning: Checking missing values, resolving queries, and logging every action with full traceability.
- Review and local lab management: Ongoing review of data from the lab to be converted into standardised units.
- Medical coding: Clinical terms are translated into regulatory-standard codes using MedDRA and the WHO Drug Dictionary.
- Database lock: Once all queries are resolved and data is clean, the database is locked to prevent further changes.
- Data export and analysis: Exporting the data for review, regulatory submission, and reporting.
Why use CDMS software? Key benefits
- Time-efficient: Accelerates time to database lock.
- Automated workflow: Reduces manual data errors through automated edit checks.
- Ready for inspection at all times: Maintains continuous audit readiness for regulatory inspection.
- Multi-site collaboration: Enables real-time monitoring across multiple trial sites.
- Scalability: Scales from single-site studies to global multi-centre trials.
- Cost-efficient: Reduces dependence on expensive CRO-managed EDC platforms.
- Secure and safe: Keeps sensitive patient data secure and GDPR-compliant.
Regulatory compliance in a CDMS
[Content to be added - see original document for text placeholder]
"The quality of a clinical trial is only as strong as the quality of the data behind it. A robust Clinical Data Management System (CDMS) ensures data integrity, regulatory compliance, and confidence in every decision."
How to choose the correct CDMS software for your clinical trial
A CDMS is instrumental in managing vast amounts of patient data and research information, and it is critical that the system facilitates efficient data collection, storage, and analysis. Therefore, selecting the most fitting clinical data management system comes down to these factors:
Selection criteria for clinical data management software
- Regulatory compliance: Adherence to industry standards like Good Clinical Practice (GCP), 21 CFR Part 11, and GDPR.
- Robust data security features: Sensitive information must be safeguarded in a consistent and trustworthy manner.
- User-friendliness: Intuitive system with minimal training required.
- Scalability: Accommodate growth and diversification of clinical trials.
- Interoperability: Can the CDMS connect with external systems such as CTMS, LIMS, ePRO platforms, and EHR systems? Integration with various data sources is essential for workflow and collaboration.
- Implementation speed: Enterprise platforms like Medidata Rave can take 4 to 12 weeks to configure. No-code platforms like Ledidi Trials go from design to first patient entry significantly faster.
- Support: For teams without dedicated IT, responsive vendor support reduces trial setup risk significantly.
- Cost structure: Enterprise platforms (Medidata, Oracle, Veeva) involve significant licensing and configuration costs. Purpose-built, no-code platforms like Ledidi reduce this cost substantially.
Technological advancements that you should consider
The latest technological advancements in clinical data management software impact how crucial CDMS has become and continues to be for the implementation of the best clinical trial design.
Artificial intelligence (AI) enhances data analysis
AI is transforming CDMS from a system that primarily stores and manages data into one that actively improves data quality and operational efficiency. Machine learning algorithms can identify missing, inconsistent, or anomalous data, automate query generation, and detect patterns that may indicate protocol deviations or safety concerns. As AI capabilities mature, CDMS platforms will increasingly support predictive risk monitoring, helping study teams address potential issues before they affect trial timelines or data integrity.
Cloud-based solutions offer scalability and remote access
Cloud-based CDMS platforms enable sponsors, CROs, and research sites to access trial data securely from anywhere, supporting global collaboration and reducing the need for complex on-premises infrastructure. They offer the flexibility to scale as studies grow, simplify software updates and validation, and accelerate study startup.
Decentralised and hybrid trial support
The rise of decentralised and hybrid clinical trials is driving demand for CDMS platforms that can integrate data from multiple sources, including ePRO, wearable devices, telemedicine platforms, EHRs, and home healthcare services. Future CDMS solutions will play a central role in consolidating these diverse data streams while maintaining data quality, traceability, and regulatory compliance.
Real-time data visualisation
Modern CDMS platforms increasingly provide real-time dashboards and visual analytics that give study teams immediate insight into recruitment, data quality, protocol compliance, and site performance. As analytics capabilities evolve, real-time visualisation will become a standard feature for improving trial oversight, operational efficiency, and risk management.
Choosing a CDMS: How our clients think
In collaboration with Ledidi, the Cambridge-based robotic surgical device manufacturer CMR Surgical used our software solution, Ledidi Core, to ensure a data-driven clinical practice that would improve the quality of care and patient outcomes. This enabled them to evaluate the Versius robotic system in paediatric urology across three NHS clinical sites (Southampton Children's Hospital, Royal Manchester Children's Hospital, and Evelina London Children's Hospital).
"We are committed to the responsible introduction of Versius across new specialties and data-driven clinical practice is integral to this, particularly in a trial setting."
By taking advantage of the Ledidi no-code designer, which allows for building forms that mirror their actual clinical workflows, they managed to save significant time and cost without compromising compliance.
Did you know?
Ledidi Trials has officially launched as a dedicated, specialised module for GxP-regulated trials. This serves as the primary software for regulatory clinical trials, designed for medtech, biotech, and Clinical Research Organisations (CROs). It is easily integrated with the other Ledidi modules, Core and Registries.
Ledidi Trials was also independently audited and confirmed audit-ready in January 2026 by Thomas Pauly CISA / DHC, ensuring compliance with key regulatory expectations, including FDA 21 CFR Part 11, ICH GCP E6 (R3), and ISPE GAMP 5.
Watch: Realise your clinical trial design with us
With Ledidi, a research group can run a clinical registry on Ledidi Registries and a manufacturer-sponsored clinical trial on Ledidi Trials within the same secure environment. This can be done without migrating data or retraining staff.
Watch more videos of Ledidi in practice
One platform for the full research lifecycle
Health data collaboration is possible through the Ledidi Core platform, which integrates data capture, analytics and collaboration in one seamless platform within a secure cloud-based environment. Ledidi's vision is a world where the health and life science community collaborates on a global scale.
About Ledidi
Ledidi is a Norwegian software company founded in 2016 by two academic surgeons and three software engineers with extensive expertise in system architecture and cloud computing.
Frequently asked questions
What does CDMS stand for?
CDMS stands for Clinical Data Management System. It is sometimes also referred to as clinical data management software or clinical research data management software.
What regulations must a CDMS comply with?
A CDMS should comply with FDA 21 CFR Part 11, Good Clinical Practice (GCP), ISPE GAMP 5, EU Annex 11, and GDPR. For trials conducted at NHS sites in the UK, compliance with the NHS Digital Data Security and Protection Toolkit is also relevant.
What are the stages of clinical data management?
Clinical data management follows seven stages: study setup, data collection, data cleaning and validation, local lab management, medical coding, database lock, and data export and analysis.
What medical coding dictionaries does a CDMS use?
The two primary medical coding dictionaries used in CDMS platforms are MedDRA (Medical Dictionary for Regulatory Activities) for adverse events and diagnoses, and the WHO Drug Dictionary for concomitant medications. Both are required for regulatory submissions to the FDA and EMA.
How long does it take to implement a CDMS?
The timeline to implement a CDMS varies. Enterprise platforms like Medidata, Oracle, or Veeva typically require 4 to 12 weeks for full configuration, while no-code platforms like Ledidi Trials significantly reduce this timeline, enabling teams to design and publish eCRFs independently without developer support.
What is the difference between CDMS and CTMS?
The CDMS is data-centric, whereas a Clinical Trial Management System (CTMS) is operationally centric. A CDMS manages the integrity, validation, and structure of clinical data; the CTMS manages trial operations, including site management, visit scheduling, and investigator payments.
Sources
- Krishnankutty B et al. Data management in clinical research: An overview. PMC/NIH. https://pmc.ncbi.nlm.nih.gov/articles/PMC3326906/
